Literature DB >> 33671684

A Review of Streptococcus pyogenes: Public Health Risk Factors, Prevention and Control.

Nelly Janira Avire1, Harriet Whiley1, Kirstin Ross1.   

Abstract

Streptococcus pyogenes, (colloquially named "group A streptococcus" (GAS)), is a pathogen of public health significance, infecting 18.1 million people worldwide and resulting in 500,000 deaths each year. This review identified published articles on the risk factors and public health prevention and control strategies for mitigating GAS diseases. The pathogen causing GAS diseases is commonly transmitted via respiratory droplets, touching skin sores caused by GAS or through contact with contaminated material or equipment. Foodborne transmission is also possible, although there is need for further research to quantify this route of infection. It was found that GAS diseases are highly prevalent in developing countries, and among indigenous populations and low socioeconomic areas in developed countries. Children, the immunocompromised and the elderly are at the greatest risk of S. pyogenes infections and the associated sequelae, with transmission rates being higher in schools, kindergartens, hospitals and residential care homes. This was attributed to overcrowding and the higher level of social contact in these settings. Prevention and control measures should target the improvement of living conditions, and personal and hand hygiene. Adherence to infection prevention and control practices should be emphasized in high-risk settings. Resource distribution by governments, especially in developed countries, should also be considered.

Entities:  

Keywords:  GAS; Strep A; group A strep; group A streptococcus; infection control; management; policy; risk assessment; streptococcus pyogenes

Year:  2021        PMID: 33671684     DOI: 10.3390/pathogens10020248

Source DB:  PubMed          Journal:  Pathogens        ISSN: 2076-0817


  7 in total

Review 1.  Acute Rheumatic Fever and Rheumatic Heart Disease: Highlighting the Role of Group A Streptococcus in the Global Burden of Cardiovascular Disease.

Authors:  Tangeni Auala; Ben'Lauro Goncalves Zavale; Amam Çhinyere Mbakwem; Ana Olga Mocumbi
Journal:  Pathogens       Date:  2022-04-21

2.  QSAR, Docking, and Molecular Dynamics Simulation Studies of Sigmacidins as Antimicrobials against Streptococci.

Authors:  Jiqing Ye; Xiao Yang; Cong Ma
Journal:  Int J Mol Sci       Date:  2022-04-07       Impact factor: 6.208

3.  Antimicrobial Biomaterial on Sutures, Bandages and Face Masks with Potential for Infection Control.

Authors:  Zehra Edis; Samir Haj Bloukh; Hamed Abu Sara; Nur Izyan Wan Azelee
Journal:  Polymers (Basel)       Date:  2022-05-10       Impact factor: 4.967

4.  Composites Based on Gellan Gum, Alginate and Nisin-Enriched Lipid Nanoparticles for the Treatment of Infected Wounds.

Authors:  Katarzyna Reczyńska-Kolman; Kinga Hartman; Konrad Kwiecień; Monika Brzychczy-Włoch; Elżbieta Pamuła
Journal:  Int J Mol Sci       Date:  2021-12-28       Impact factor: 5.923

5.  Editorial: From Pathogenic Infections to Inflammation and Disease - the Tumultuous Road of the 'Cytokine Storm'.

Authors:  Henry Puerta-Guardo
Journal:  Front Cell Infect Microbiol       Date:  2022-01-10       Impact factor: 5.293

6.  Fatal Pediatric Streptococcal Infection: A Clinico-Pathological Study.

Authors:  Anita Nagy; Jeanette A Reyes; David A Chiasson
Journal:  Pediatr Dev Pathol       Date:  2022-02-28

Review 7.  Streptococcus pyogenes ("Group A Streptococcus"), a Highly Adapted Human Pathogen-Potential Implications of Its Virulence Regulation for Epidemiology and Disease Management.

Authors:  Nikolai Siemens; Rudolf Lütticken
Journal:  Pathogens       Date:  2021-06-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.